1. Home
  2. GBIO vs ZCMD Comparison

GBIO vs ZCMD Comparison

Compare GBIO & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • ZCMD
  • Stock Information
  • Founded
  • GBIO 2016
  • ZCMD 2012
  • Country
  • GBIO United States
  • ZCMD China
  • Employees
  • GBIO N/A
  • ZCMD N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • ZCMD Other Consumer Services
  • Sector
  • GBIO Health Care
  • ZCMD Real Estate
  • Exchange
  • GBIO Nasdaq
  • ZCMD Nasdaq
  • Market Cap
  • GBIO 29.2M
  • ZCMD 28.5M
  • IPO Year
  • GBIO 2020
  • ZCMD 2020
  • Fundamental
  • Price
  • GBIO $0.52
  • ZCMD $1.10
  • Analyst Decision
  • GBIO Strong Buy
  • ZCMD
  • Analyst Count
  • GBIO 4
  • ZCMD 0
  • Target Price
  • GBIO $7.33
  • ZCMD N/A
  • AVG Volume (30 Days)
  • GBIO 1.8M
  • ZCMD 241.3K
  • Earning Date
  • GBIO 08-06-2025
  • ZCMD 01-01-0001
  • Dividend Yield
  • GBIO N/A
  • ZCMD N/A
  • EPS Growth
  • GBIO N/A
  • ZCMD N/A
  • EPS
  • GBIO N/A
  • ZCMD N/A
  • Revenue
  • GBIO $24,556,000.00
  • ZCMD $15,864,773.00
  • Revenue This Year
  • GBIO N/A
  • ZCMD N/A
  • Revenue Next Year
  • GBIO N/A
  • ZCMD N/A
  • P/E Ratio
  • GBIO N/A
  • ZCMD N/A
  • Revenue Growth
  • GBIO 146.47
  • ZCMD N/A
  • 52 Week Low
  • GBIO $0.30
  • ZCMD $0.95
  • 52 Week High
  • GBIO $3.65
  • ZCMD $2.97
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 66.42
  • ZCMD 47.03
  • Support Level
  • GBIO $0.32
  • ZCMD $1.10
  • Resistance Level
  • GBIO $0.59
  • ZCMD $1.24
  • Average True Range (ATR)
  • GBIO 0.05
  • ZCMD 0.08
  • MACD
  • GBIO 0.02
  • ZCMD -0.01
  • Stochastic Oscillator
  • GBIO 76.34
  • ZCMD 14.93

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.

Share on Social Networks: